Genzyme Tissue Repair
This article was originally published in The Gray Sheet
Executive SummaryFirm is the developer of the NeuroCell porcine neural tissue for treatment of neurodegenerative diseases, and not Genzyme Transgenics, as was reported in "The Gray Sheet" (March 15, p. 32)
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.